INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer...
The post Pivotal phase III trial launched in recurrent ovarian cancer appeared first on European Pharmaceutical Review.
Original Article: Pivotal phase III trial launched in recurrent ovarian cancer